GB460193A - Process for the manufacture of a stable product therapeutically useful in relation to bleeding - Google Patents

Process for the manufacture of a stable product therapeutically useful in relation to bleeding

Info

Publication number
GB460193A
GB460193A GB20644/35A GB2064435A GB460193A GB 460193 A GB460193 A GB 460193A GB 20644/35 A GB20644/35 A GB 20644/35A GB 2064435 A GB2064435 A GB 2064435A GB 460193 A GB460193 A GB 460193A
Authority
GB
United Kingdom
Prior art keywords
soluble organic
water
bleeding
precipitated
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB20644/35A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
I G FARBENDUSTRIE AG
IG Farbenindustrie AG
Original Assignee
I G FARBENDUSTRIE AG
IG Farbenindustrie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I G FARBENDUSTRIE AG, IG Farbenindustrie AG filed Critical I G FARBENDUSTRIE AG
Priority to GB20644/35A priority Critical patent/GB460193A/en
Publication of GB460193A publication Critical patent/GB460193A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Stable products having the property of shortening the period of bleeding are prepared by evaporating to dryness under sterile conditions pressed juices or extracts from the spinal cord or brain of mammals, e.g. calves. The pressed juices are purified by centrifuging and filtering. Extracts are obtained by the use of water or dilute aqueous solutions of salts, e.g. sodium chloride, or water and aqueous mixtures of soluble organic substances, e.g. alcohols, pyridine, dimethylamine. The coagulable proteins may be precipitated by heating to 80 DEG C. or by addition of water soluble organic liquids or strong solutions thereof or of salts. By addition of water soluble organic liquids in greater amount, the active principle may be precipitated from the extract or juice and is then extracted from the precipitate by means of aqueous solvents, e.g. 50 per cent alcohol. The evaporation of the liquid preparations is conducted at low temperatures and reduced pressures. Specification 349,257 is referred to.
GB20644/35A 1935-07-19 1935-07-19 Process for the manufacture of a stable product therapeutically useful in relation to bleeding Expired GB460193A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB20644/35A GB460193A (en) 1935-07-19 1935-07-19 Process for the manufacture of a stable product therapeutically useful in relation to bleeding

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20644/35A GB460193A (en) 1935-07-19 1935-07-19 Process for the manufacture of a stable product therapeutically useful in relation to bleeding

Publications (1)

Publication Number Publication Date
GB460193A true GB460193A (en) 1937-01-19

Family

ID=10149318

Family Applications (1)

Application Number Title Priority Date Filing Date
GB20644/35A Expired GB460193A (en) 1935-07-19 1935-07-19 Process for the manufacture of a stable product therapeutically useful in relation to bleeding

Country Status (1)

Country Link
GB (1) GB460193A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005005460A1 (en) * 2003-07-10 2005-01-20 Novo Nordisk A/S Method of washing and concentrating protein precipitates by means of a centrifugal field and fluidization conditions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005005460A1 (en) * 2003-07-10 2005-01-20 Novo Nordisk A/S Method of washing and concentrating protein precipitates by means of a centrifugal field and fluidization conditions

Similar Documents

Publication Publication Date Title
Roboz et al. A Mucilage from Aloe Vera1
US2353016A (en) Physiologically active substance
GB460193A (en) Process for the manufacture of a stable product therapeutically useful in relation to bleeding
US2154934A (en) Purified bee poison
US2099708A (en) Therapeutic product and method of making same
GB475291A (en) Process of preparing nutritive amino-acid preparations
DE802332C (en) Process for the production of tasteless yeast and yeast extracts or yeast preparations
SU741882A1 (en) Method of producing extract "mammotocin" having oxytotic action
DE671856C (en) Process for the manufacture of a long lasting product that affects bleeding
US2080430A (en) Product for stimulating blood cell formation and method of making it
GB417513A (en) Method of producing an enzyme for treatment of malignant growths
GB479487A (en) Manufacture of stable therapeutic products from intestinal mucous membrane
DE698136C (en) influential durable product
GB463464A (en) Improved manufacture of blood product
US1579828A (en) Process for producing a preparation for treating arteriosclerosis
US1840134A (en) Production of organic products from meat pickle brine
Ihde et al. The Chemistry of the Rye Germ. VI. Allantoin and Other Acetone-Extractives1
GB458885A (en) Improvements in and relating to diagnostic agents and the production thereof
ES270317A1 (en) Viscumic acid and salts thereof
GB423192A (en) The manufacture of a physiologically active preparation from embryonal tissue
GB906819A (en) Parenteral solution for diagnostic test of cancer and a process of preparing same
GB425104A (en) Process for the production of an antithyroidal substance
AT156660B (en) Process for the manufacture of a long-lasting product that affects bleeding.
Oh-Uti et al. Toxic Substances in Cancer II. Effect on the Movement of Paramecium of the Extract of Gastric Carcinoma Tissue (1 st Report)
GB482826A (en) Manufacture of extracts of spleen or liver